Searched for
ZYDUS PHARMACEUTICALS USA
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Zydus settles US Mirabegron patent dispute with Astellas for $120 millionZydus Lifesciences and its US subsidiary have settled patent litigation with Astellas Pharma over Astellas' Myrbetriq. Zydus will pay Astel...
- Zydus ties up with Synthon BV for multiple sclerosis drug launch in USZydus Lifesciences will launch a generic drug for multiple sclerosis in the United States. This is through a partnership with Synthon BV. T...
- Zydus unit recalls 7,248 bottles of Oxybutynin Chloride tablets in USNew Jersey-based Zydus Pharmaceuticals (USA) Inc. is recalling the affected lot due to "Failed Dissolution Specifications", the USFDA state...
- Zydus recalls over 55k bottles of generic drug in USUSFDA said the company is recalling the product due to "failed impurities/ degradation specifications". An out-of-specification (OOS) resul...
- Dr Reddy's, Zydus Pharma recall products in US marketAs per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due ...
- Indian drug firms recall various products in US marketWhile Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.
- Zydus gets USFDA nod for schizophrenia treatment drugThe company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said...
- Zydus Pharma recalls 44.8 K bottles of antidepressant in USThe reason for recall is presence of foreign tablets. "Risperidone tablets were found in bottle of paroxetine tablets", the report said.
- Zydus' Nesher Pharma gets USFDA nod to market influenza drugZydus' Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said th...
- US court rules in favour of Zydus Cadila in patent caseThe US Court of Appeals for the Federal Circuit has affirmed judgement in favour of Zydus Pharmaceuticals (USA) Inc.
- Cadila Healthcare settles patent litigation related to Livalo tabletsThe company and its subsidiary have finalised an agreement with Kowa Company and Nissan Chemical Industries to settle all outstanding paten...
- Zydus group firm Nesher Pharmaceuticals gets USFDA nod for a drug"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.
- Zydus Pharma Inc recalls 9,504 bottles of Risperidone tabletsRisperidone tablets are used in the treatment of schizophrenia. "The reason for recall is "out of specification for a known degradant," it ...
- Cadila Healthcare recalls 19,536 bottles of cough treatment drug in USDrug firm Cadila is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leakin...
- Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Cadila Healthcare recalls blood pressure drug in the USThe recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.
- Zydus Cadila Q1 net up 15.38% at Rs 229.82 croreAhmedabad-based Zydus Cadila today said its consolidated net profit rose by 15.38 per cent to Rs 229.82 crore in the first quarter ended Ju...
- Zydus plans to buy US drug cos for $60 mnZydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...
Load More
